SCINAI IMMUNOTHERAPEUTICS LT (SCNI)

US09073Q3039 - ADR

3.4414  +0.02 (+0.63%)

After market: 3.4 -0.04 (-1.2%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
N/A
EBITDA
YoY % growth
-2.089M-2.75M
-31.64%
-2.941M
-6.94%
-6.458M
-119.62%
-21.382M
-231.08%
-21.54M
-0.74%
2.842M
113.19%
-10.035M
-453.15%
-10.499M
-4.62%
-9.192M
12.45%
N/A
EBIT
YoY % growth
-2.278M-2.912M
-27.80%
-3.103M
-6.56%
-6.581M
-112.10%
-21.455M
-226.02%
-22.002M
-2.55%
2.133M
109.70%
-10.783M
-605.49%
-11.061M
-2.58%
-9.706M
12.25%
N/A
-110.18%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A
98.72%
N/A
-1,200.00%
N/A
61.54%
N/AN/AN/AN/A
99.93%
-18.70
-61,011.11%
N/A
98.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
-4.70
-4,507.84%
-6.321.6225.68%
Q3 2023
Q2Q % growth
8.00
7,900.00%
-10.1018.10179.22%
Q2 2023
Q2Q % growth
-11.10
-455.00%
-9.28-1.82-19.59%
Q1 2023
Q2Q % growth
-10.90
45.50%
-7.45-3.45-46.39%
Q4 2022
Q2Q % growth

99.62%
-0.10%
Q3 2022
Q2Q % growth
0.10 -1.021.12109.80%
Q2 2022
Q2Q % growth
-2.00 -10.718.7181.33%
Q1 2022
Q2Q % growth
-20.00 -10.20-9.80-96.08%
Q4 2021
Q2Q % growth
-27.00 -8.67-18.33-211.42%
Q2 2020
Q2Q % growth
-114.00
44.12%
-1.02-112.98-11,076.47%
Q1 2020
Q2Q % growth
-10.00 -1.02-8.98-880.39%
Q3 2019
Q2Q % growth
-80.00 -3.06-76.94-2,514.38%
Q2 2019
Q2Q % growth
-204.00 -2.04-201.96-9,900.00%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A N/A N/A